Management of Pruritus Associated with Hyperbilirubinemia
Cholestyramine is the most effective first-line medication for relieving pruritus associated with hyperbilirubinemia due to its safety profile and mechanism of binding bile acids in the intestine. 1
First-Line Therapy: Cholestyramine
Cholestyramine works by binding bile acids in the intestine to form an insoluble complex that is excreted in feces, preventing reabsorption of bile acids and reducing their deposition in dermal tissue, which causes pruritus 2.
Dosing and Administration:
- Starting dose: 4 g/day
- Maximum dose: 16 g/day as tolerated 1
- Administration timing: Give at breakfast time (1 hour before or after eating)
- Spacing: Must be given 2-4 hours before or after other medications (especially UDCA)
- Palatability tip: Mix with orange squash and refrigerate overnight 1
Monitoring:
- Primary side effect: Constipation
- Watch for medication interactions due to binding properties 1
Second-Line Therapy: Rifampicin
If cholestyramine is ineffective or poorly tolerated, rifampicin is the recommended second-line agent 1, 3.
Dosing and Administration:
- Starting dose: 150 mg once to twice daily
- Titrate upward based on symptoms and LFT monitoring
- Maximum dose: 600 mg daily 1, 3
Monitoring:
- Check LFTs after 2-4 weeks of treatment
- Use with caution in advanced liver disease
- Consider vitamin K supplementation if patient is icteric 1
- Monitor for hepatotoxicity 1
Additional Treatment Options
For Refractory Cases:
Gabapentin
- Dose titrate according to side effects and efficacy 1
Naltrexone
- Starting dose: 12.5 mg/day
- Target dose: 50 mg/day
- Titrate slowly to avoid withdrawal symptoms
- Some patients may require intravenous induction 1
Sertraline
Bezafibrate
Physical Therapies for Severe Cases:
- Broadband UVB phototherapy 3
- Nasobiliary drainage (temporary relief but technically complicated) 1
- Plasmapheresis or albumin exchange (for extreme situations) 1
- Liver transplantation (for persistent, intractable pruritus) 1, 3
Special Considerations
For Pregnant Women with Intrahepatic Cholestasis:
- UDCA (10-15 mg/kg/day) is the preferred treatment for pruritus in pregnancy
- Typical regimens: 300 mg twice or three times daily, or 500 mg twice daily
- Can be titrated to maximum 21 mg/kg/day if pruritus is not relieved 1
Pitfalls and Caveats:
- Antihistamines have limited specific benefit for cholestatic pruritus but may help as adjuncts due to sedative properties 1
- Topical antipruritics (menthol creams, calamine lotion) have limited efficacy as cholestatic pruritus is typically widespread 1
- UDCA may improve pruritus in primary biliary cirrhosis but can worsen symptoms in some late-stage (III-IV) patients 4, 5
- Fibrates may improve pruritus but require careful monitoring for adverse effects including musculoskeletal pain and potential nephrotoxicity 1
By following this stepwise approach to managing pruritus associated with hyperbilirubinemia, clinicians can effectively address this distressing symptom while minimizing adverse effects.